OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis
Bhavani Shankara Bagepally, Yogesh K. Gurav, Thunyarat Anothaisintawee, et al.
Value in Health (2019) Vol. 22, Iss. 12, pp. 1458-1469
Open Access | Times Cited: 34
Bhavani Shankara Bagepally, Yogesh K. Gurav, Thunyarat Anothaisintawee, et al.
Value in Health (2019) Vol. 22, Iss. 12, pp. 1458-1469
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies
Lihui Zhou, Wenxin Yan, Shu Li, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 35
Lihui Zhou, Wenxin Yan, Shu Li, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 35
Meta-analysis of economic evaluation studies: data harmonisation and methodological issues
Bhavani Shankara Bagepally, Usa Chaikledkaew, Nathorn Chaiyakunapruk, et al.
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 34
Bhavani Shankara Bagepally, Usa Chaikledkaew, Nathorn Chaiyakunapruk, et al.
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 34
Cost-effectiveness of Internet Interventions Compared With Treatment as Usual for People With Mental Disorders: Systematic Review and Meta-analysis of Randomized Controlled Trials
Pieter J. Rohrbach, Alexandra E. Dingemans, Catharine Evers, et al.
Journal of Medical Internet Research (2022) Vol. 25, pp. e38204-e38204
Open Access | Times Cited: 28
Pieter J. Rohrbach, Alexandra E. Dingemans, Catharine Evers, et al.
Journal of Medical Internet Research (2022) Vol. 25, pp. e38204-e38204
Open Access | Times Cited: 28
Economic evaluation of seasonal influenza vaccination in elderly and health workers: A systematic review and meta-analysis
Piyameth Dilokthornsakul, Lan My Le, Ammarin Thakkinstian, et al.
EClinicalMedicine (2022) Vol. 47, pp. 101410-101410
Open Access | Times Cited: 24
Piyameth Dilokthornsakul, Lan My Le, Ammarin Thakkinstian, et al.
EClinicalMedicine (2022) Vol. 47, pp. 101410-101410
Open Access | Times Cited: 24
Incremental Net Monetary Benefit of Bariatric Surgery: Systematic Review and Meta-Analysis of Cost-Effectiveness Evidences
Prapaporn Noparatayaporn, Montarat Thavorncharoensap, Usa Chaikledkaew, et al.
Obesity Surgery (2021) Vol. 31, Iss. 7, pp. 3279-3290
Open Access | Times Cited: 31
Prapaporn Noparatayaporn, Montarat Thavorncharoensap, Usa Chaikledkaew, et al.
Obesity Surgery (2021) Vol. 31, Iss. 7, pp. 3279-3290
Open Access | Times Cited: 31
Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence
Mario Cesare Nurchis, Maria Teresa Riccardi, Francesca Clementina Radio, et al.
Health Policy (2022) Vol. 126, Iss. 4, pp. 337-345
Closed Access | Times Cited: 19
Mario Cesare Nurchis, Maria Teresa Riccardi, Francesca Clementina Radio, et al.
Health Policy (2022) Vol. 126, Iss. 4, pp. 337-345
Closed Access | Times Cited: 19
Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies
M. Sakil Syeed, Priyanka Ghule, Lan Le, et al.
Value in Health (2022) Vol. 26, Iss. 4, pp. 598-611
Open Access | Times Cited: 19
M. Sakil Syeed, Priyanka Ghule, Lan Le, et al.
Value in Health (2022) Vol. 26, Iss. 4, pp. 598-611
Open Access | Times Cited: 19
Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies
Bhavani Shankara Bagepally, Usa Chaikledkaew, Yogesh Gurav, et al.
BMJ Open Diabetes Research & Care (2020) Vol. 8, Iss. 1, pp. e001020-e001020
Open Access | Times Cited: 29
Bhavani Shankara Bagepally, Usa Chaikledkaew, Yogesh Gurav, et al.
BMJ Open Diabetes Research & Care (2020) Vol. 8, Iss. 1, pp. e001020-e001020
Open Access | Times Cited: 29
Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations
Kamolpat Chaiyakittisopon, Oraluck Pattanaprateep, Narisa Ruenroengbun, et al.
The European Journal of Health Economics (2021) Vol. 22, Iss. 4, pp. 571-584
Open Access | Times Cited: 21
Kamolpat Chaiyakittisopon, Oraluck Pattanaprateep, Narisa Ruenroengbun, et al.
The European Journal of Health Economics (2021) Vol. 22, Iss. 4, pp. 571-584
Open Access | Times Cited: 21
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis
Rini Noviyani, Sitaporn Youngkong, Surakit Nathisuwan, et al.
BMJ evidence-based medicine (2021) Vol. 27, Iss. 4, pp. 215-223
Open Access | Times Cited: 19
Rini Noviyani, Sitaporn Youngkong, Surakit Nathisuwan, et al.
BMJ evidence-based medicine (2021) Vol. 27, Iss. 4, pp. 215-223
Open Access | Times Cited: 19
Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies
S. Sajith Kumar, Bhavani Shankara Bagepally, Akhil Sasidharan
Clinical Drug Investigation (2023) Vol. 43, Iss. 2, pp. 97-108
Closed Access | Times Cited: 7
S. Sajith Kumar, Bhavani Shankara Bagepally, Akhil Sasidharan
Clinical Drug Investigation (2023) Vol. 43, Iss. 2, pp. 97-108
Closed Access | Times Cited: 7
Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies
Bhavani Shankara Bagepally, Akhil Sasidharan
European Journal of Clinical Pharmacology (2021) Vol. 78, Iss. 3, pp. 351-363
Closed Access | Times Cited: 15
Bhavani Shankara Bagepally, Akhil Sasidharan
European Journal of Clinical Pharmacology (2021) Vol. 78, Iss. 3, pp. 351-363
Closed Access | Times Cited: 15
Incremental net benefit of cholecystectomy compared with alternative treatments in people with gallstones or cholecystitis: a systematic review and meta-analysis of cost–utility studies
Bhavani Shankara Bagepally, S. Sajith Kumar, Meenakumari Natarajan, et al.
BMJ Open Gastroenterology (2022) Vol. 9, Iss. 1, pp. e000779-e000779
Open Access | Times Cited: 11
Bhavani Shankara Bagepally, S. Sajith Kumar, Meenakumari Natarajan, et al.
BMJ Open Gastroenterology (2022) Vol. 9, Iss. 1, pp. e000779-e000779
Open Access | Times Cited: 11
Cost-utility of Ranolazine for Chronic Stable Angina Pectoris: Systematic Review and Meta-analysis
Lavanya Ayyasamy, Bhavani Shankara Bagepally
Clinical Therapeutics (2023) Vol. 45, Iss. 5, pp. 458-465
Closed Access | Times Cited: 6
Lavanya Ayyasamy, Bhavani Shankara Bagepally
Clinical Therapeutics (2023) Vol. 45, Iss. 5, pp. 458-465
Closed Access | Times Cited: 6
Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies
Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, et al.
Journal of Asthma (2023) Vol. 60, Iss. 9, pp. 1702-1714
Closed Access | Times Cited: 5
Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, et al.
Journal of Asthma (2023) Vol. 60, Iss. 9, pp. 1702-1714
Closed Access | Times Cited: 5
Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies
S. Sajith Kumar, Madhumitha Haridoss, Krishnamurthy Venkataraman, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
S. Sajith Kumar, Madhumitha Haridoss, Krishnamurthy Venkataraman, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus
Henrik Vitus Bering Laursen, Emmelie Ploug Jørgensen, Peter Vestergaard, et al.
PharmacoEconomics (2023) Vol. 41, Iss. 11, pp. 1469-1514
Open Access | Times Cited: 4
Henrik Vitus Bering Laursen, Emmelie Ploug Jørgensen, Peter Vestergaard, et al.
PharmacoEconomics (2023) Vol. 41, Iss. 11, pp. 1469-1514
Open Access | Times Cited: 4
Diabetes and Hypertension
Mounika Vejendla, Meghana Anagani, Terry Oroszi
Journal of Diabetes Mellitus (2024) Vol. 15, Iss. 01, pp. 25-39
Closed Access | Times Cited: 1
Mounika Vejendla, Meghana Anagani, Terry Oroszi
Journal of Diabetes Mellitus (2024) Vol. 15, Iss. 01, pp. 25-39
Closed Access | Times Cited: 1
Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective
Bhavani Shankara Bagepally, Usa Chaikledkaew, Sitaporn Youngkong, et al.
ClinicoEconomics and Outcomes Research (2021) Vol. Volume 13, pp. 897-907
Open Access | Times Cited: 10
Bhavani Shankara Bagepally, Usa Chaikledkaew, Sitaporn Youngkong, et al.
ClinicoEconomics and Outcomes Research (2021) Vol. Volume 13, pp. 897-907
Open Access | Times Cited: 10
Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations
Alper Sönmez, Hani Sabbour, Akram Echtay, et al.
Journal of Diabetes (2022) Vol. 14, Iss. 5, pp. 315-333
Open Access | Times Cited: 7
Alper Sönmez, Hani Sabbour, Akram Echtay, et al.
Journal of Diabetes (2022) Vol. 14, Iss. 5, pp. 315-333
Open Access | Times Cited: 7
Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies
Akhil Sasidharan, Bhavani Shankara Bagepally, S. Sajith Kumar, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0264563-e0264563
Open Access | Times Cited: 7
Akhil Sasidharan, Bhavani Shankara Bagepally, S. Sajith Kumar, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0264563-e0264563
Open Access | Times Cited: 7
Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence
Sariya Udayachalerm, Maranda Renouard, Thunyarat Anothaisintawee, et al.
Journal of Medical Economics (2021) Vol. 25, Iss. 1, pp. 26-37
Open Access | Times Cited: 9
Sariya Udayachalerm, Maranda Renouard, Thunyarat Anothaisintawee, et al.
Journal of Medical Economics (2021) Vol. 25, Iss. 1, pp. 26-37
Open Access | Times Cited: 9
Mapping the value for money of precision medicine: a systematic literature review and meta-analysis
Wenjia Chen, Nigel Chong Boon Wong, Yi Wang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 3
Wenjia Chen, Nigel Chong Boon Wong, Yi Wang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 3
Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis
Sajesh K. Veettil, Jordi Harris, M. Sakil Syeed, et al.
Thrombosis Research (2022) Vol. 216, pp. 74-83
Closed Access | Times Cited: 4
Sajesh K. Veettil, Jordi Harris, M. Sakil Syeed, et al.
Thrombosis Research (2022) Vol. 216, pp. 74-83
Closed Access | Times Cited: 4
JAK2 V617F as a Marker for Long-Term Disease Progression and Mortality in Polycythemia Vera and its Role in Economic Modeling
Jonas Hjelmgren, Kristoffer Nilsson, Gunnar Birgegård
Journal of health economics and outcomes research (2020), pp. 61-70
Open Access | Times Cited: 4
Jonas Hjelmgren, Kristoffer Nilsson, Gunnar Birgegård
Journal of health economics and outcomes research (2020), pp. 61-70
Open Access | Times Cited: 4
